Bellevue Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-28,000
| Closed | -$3.41M | – | 139 |
|
|
2018
Q3 | $3.41M | Buy |
+28,000
| New | +$3.41M | 0.22% | 90 |
|
|
2018
Q1 | – | Sell |
-13,500
| Closed | -$1.44M | – | 127 |
|
|
2017
Q4 | $1.44M | Sell |
13,500
-13,500
| -50% | -$1.44M | 0.15% | 96 |
|
|
2017
Q3 | $3M | Buy |
27,000
+6,000
| +29% | +$667K | 0.31% | 68 |
|
|
2017
Q2 | $2.17M | Sell |
21,000
-15,000
| -42% | -$1.55M | 0.26% | 78 |
|
|
2017
Q1 | $3.52M | Buy |
36,000
+24,000
| +200% | +$2.35M | 0.47% | 60 |
|
|
2016
Q4 | $1.06M | Sell |
12,000
-28,500
| -70% | -$2.52M | 0.22% | 82 |
|
|
2016
Q3 | $3.91M | Buy |
40,500
+15,000
| +59% | +$1.45M | 0.71% | 46 |
|
|
2016
Q2 | $2.19M | Buy |
25,500
+18,000
| +240% | +$1.54M | 0.41% | 69 |
|
|
2016
Q1 | $652K | Buy |
+7,500
| New | +$652K | 0.12% | 104 |
|